Health Care/Hospital

Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus

HONG KONG, March 10 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd ("Obio"/ "the Company") announced the discovery of a new indication of a drug, TG21, against main strains of influenza virus (including avian and human influenza strains) such as H3N2 and H5N1. The process leading to cli...

2009-03-10 08:00 536

Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant

Added Capacity Is First Step In Company's 2009 Expansion Strategy NEW YORK, March 10 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) today announced that it has acquired 8.6 acres of land located in Xi'an, thirty-five kilometers from the Company's opera...

2009-03-10 22:00 491

American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule

NEW YORK, March 9 /PRNewswire-Asia/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a China-based pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, announc...

2009-03-09 18:01 767

American Oriental Bioengineering Reports Fourth Quarter and Full Year 2008 Financial Results

Revenue Increased 68% to $96.3 Million in 4Q08 and 65% to $264.6 Million in FY08 FY08 Non-GAAP Net Income up 45% to $62.7 Million, or $0.76 per Diluted Share 4Q08 Non-GAAP Net Income up 43% $21.7 Million, or $0.25 per Diluted Share NEW YORK, March 9 /PRNewswire-Asia-FirstCall/ -- Americ...

2009-03-09 18:00 521

Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status

BEIJING, March 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alternext US: SVA), a leading developer and provider of vaccines in China, announced today that the Chinese government, led by the Ministry of Science and Technology of China, the Ministry of Finance and the State Administration o...

2009-03-09 20:00 642

China Yingxia International, Inc.'s chairwoman and CEO is in talks with investors in China

HARBIN, China, March 6 /PRNewswire-Asia-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of nutritional food products, dietary s...

2009-03-07 05:30 485

China Medical Technologies Senior Management Purchased Company Shares

BEIJING, March 6 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that each of Mr. Xiaodong Wu, the Company’s Chairman ...

2009-03-06 20:00 561

CFO of Genesis Pharmaceuticals Gives Live Interview on Bloomberg TV Asia

LAIYANG, China, March 6 /PRNewswire-Asia-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that its CFO, Ms Elsa Sung, gav...

2009-03-06 22:00 484

China-Biotics, Inc. Appoints New Chief Financial Officer

SHANGHAI, March 6 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced Lewis Fan will succeed Raymond...

2009-03-06 21:00 537

Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009

NANJING, China, March 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 fourth...

2009-03-02 14:13 591

3SBio Inc. Receives Official Recognition as a ‘High-Tech Enterprise’

SHENYANG, China, March 5 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that, in accordance with the relevant provisions issued by the Office o...

2009-03-05 21:30 553

Mindray Announces 2008 Fourth Quarter and Full Year Results

SHENZHEN, China, March 5 /PRNewswire-Asia/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2008. The f...

2009-03-05 06:00 579

Mindray Appoints Mr. Ronald Ede as Chief Financial Officer

-- Ms. Joyce Hsu Will Remain With Mindray as a Director -- SHENZHEN, China, March 5 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Ronald Ede a...

2009-03-05 06:00 680

Chindex International, Inc. to Participate in the Piper Jaffray & ChinaVenture Investment Conference 2009

Investing in China: Challenges & Opportunities Arising from Economic Downturn BETHESDA, Md., March 5 /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today an...

2009-03-05 05:01 604

China Shenghuo Announces Management Expansion and Enhanced Internal Controls

KUNMING, China, March 4 /PRNewswire-Asia/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" or the "Company"), today announced the expansion of its senior management team to better align with the Company's business outlook, to optimize operations, and inc...

2009-03-04 20:30 575

China Sky One Medical Inc. Gets SFDA Approval for Calcium Folinate Injection

- Paeonol Gel and Mei Lu Gel Enter into Clinical Trials - HARBIN, China, March 3 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People’s Repub...

2009-03-03 22:00 580

Tigermed and Qiming Venture Grant Asset Injection to MacroStat

Win-win Cooperation Between China Leading CROs, Boosting Full Service Capability HANGZHOU, China, March 3 /PRNewswire-Asia/ -- Tigermed Consulting Co., Ltd, a leading Contract Research Organization (CRO) in China, and Qiming Venture, a premier venture capital firm based in Shanghai jo...

2009-03-04 08:30 862

Align Technology Announces International Availability of Invisalign Teen(TM)

SANTA CLARA, Calif., March 3 /PRNewswire-Asia/ -- Align Technology, Inc. (Nasdaq: ALGN) today announced the international availability of Invisalign Teen(TM) for non-adult, comprehensive orthodontic treatment. Invisalign Teen is based on the innovative technology and demonstrated effectiveness o...

2009-03-03 13:45 687

China Medical Technologies Reports Third Fiscal Quarter Financial Results

BEIJING, March 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the thi...

2009-03-02 19:45 635

Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility

Annual Production Capacity Increased to 20 Million Doses BEIJING, March 2 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Alternext US: SVA), a leading provider of vaccines in China, today announced that it has received the Good Manufacturing Practice (GMP) certification for its recen...

2009-03-02 21:00 626
1 ... 701702703704705706707 ... 774